Dimitrios Bafaloukos, MD | Authors

Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer

January 01, 1998

In a phase II study, 66 patients with advanced breast cancer (median age 56 years; range, 28 to 75 years) were treated with paclitaxel (Taxol), 175 mg/m² infused over 3 hours, and carboplatin (Paraplatin), dosed to attain an